# Cephalexin

NDC: 51655-028
Generic name: Cephalexin
Labeler / Manufacturer: Northwind Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20141106
Marketing ended: 20260831
FDA application: ANDA090836

## Active ingredients

- CEPHALEXIN: 500 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51655-028"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51655-028
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=89bb3920-69bf-4818-b573-4bd845f6e2d5